Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Can microbiota research change our understanding of neurodegenerative diseases?

Literature DB >> 27033377

Can microbiota research change our understanding of neurodegenerative diseases?

Abstract

Entities: Disease

Keywords: Alzheimer's disease; Parkinson's disease; amyloid; amyotrophic lateral sclerosis; biomarker; gut–brain-axis; microbiome; microbiota; neuroinflammation

Mesh：

Year: 2016 PMID： 27033377 DOI： 10.2217/nmt-2015-0012

Source DB: PubMed Journal: Neurodegener Dis Manag ISSN： 1758-2024

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Authors: Paolo Riccio; Rocco Rossano
Journal: Neurotherapeutics Date: 2018-01 Impact factor: 7.620

Review 2. Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus.

Authors: Yuhai Zhao; Vivian Jaber; Walter J Lukiw
Journal: Front Cell Infect Microbiol Date: 2017-07-11 Impact factor: 5.293

3. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.

Authors: Yan-Shi Hu; Juncai Xin; Ying Hu; Lei Zhang; Ju Wang
Journal: Alzheimers Res Ther Date: 2017-04-27 Impact factor: 6.982

4. Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the P_R EDIGT score.

Authors: Michael G Schlossmacher; Julianna J Tomlinson; Goncalo Santos; Bojan Shutinoski; Earl G Brown; Douglas Manuel; Tiago Mestre
Journal: Eur J Neurosci Date: 2016-12-27 Impact factor: 3.386

Can microbiota research change our understanding of neurodegenerative diseases?

Review 1. Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Review 2. Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus.

3. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.

4. Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the P_R EDIGT score.

5. Are There Modifiable Environmental Factors Related to Amyotrophic Lateral Sclerosis?

Review 6. The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease.

Review 7. Application of Precision Medicine in Neurodegenerative Diseases.

8. Changes of intestinal flora in patients with systemic lupus erythematosus in northeast China.

Review 9. Therapies for Prevention and Treatment of Alzheimer's Disease.

10. Biotic/Abiotic Stress-Driven Alzheimer's Disease.

Can microbiota research change our understanding of neurodegenerative diseases?

Review 1. Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Review 2. Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus.

3. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.

4. Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.

5. Are There Modifiable Environmental Factors Related to Amyotrophic Lateral Sclerosis?

Review 6. The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease.

Review 7. Application of Precision Medicine in Neurodegenerative Diseases.

8. Changes of intestinal flora in patients with systemic lupus erythematosus in northeast China.

Review 9. Therapies for Prevention and Treatment of Alzheimer's Disease.

10. Biotic/Abiotic Stress-Driven Alzheimer's Disease.

4. Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the P_R EDIGT score.